| Company/Division name | Tonix Pharmaceuticals Holding Corp. |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Hamilton |
| State(s) reshored to: | MT |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, bioscience |
| Product(s) reshored | TNX-1800, COVID-19 vaccine,TNX-801 |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Impact on domestic economy, Lean/other business process improvement techniques, Other, Covid-19 |
